We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Non-Invasive MR Elastography Could Provide Alternative to Liver Biopsy in Obese Patients

By MedImaging International staff writers
Posted on 17 Mar 2023
Print article
Image: New approaches to 3D MRE sequences could help measure liver fibrosis and inflammation simultaneously in obese patients (Photo courtesy of KCL)
Image: New approaches to 3D MRE sequences could help measure liver fibrosis and inflammation simultaneously in obese patients (Photo courtesy of KCL)

Three-dimensional MR elastography (MRE) scans have the potential to simultaneously assess liver fibrosis and inflammation. However, existing 3D MRE methods present several challenges, such as requiring multiple sequences, each requiring the patient to hold their breath, which can reduce the precision of the liver’s geometric alignment and hinder clinical acceptance. This issue is exacerbated in obese patients, as their high body mass index (BMI) can interfere with the penetration of mechanical waves. To address these challenges, researchers have investigated a new approach that involves a single breath-hold, which obese patients can more easily tolerate and reproduce.

In a technical development study, researchers at King’s College London (KCL, London, UK) have demonstrated how a single 17-second breath-hold successfully reduced the overall MRE sequence acquisition time including multiple slices, wave offsets and motion encodings. For the study, the researchers prospectively enrolled individuals between the period November 2020 and December 2021 and divided them into two groups. Group 1 comprised healthy volunteers (n = 10) who acted as controls to compare the single breath-hold 3D MRE sequence with a multiple–breath-hold 3D MRE sequence. Group 2 comprised liver patients (n = 10) who served as participants to evaluate the clinical feasibility of the single breath-hold 3D MRE sequence in measuring liver fibrosis and inflammation. The controls and participants were scanned at 60 Hz mechanical excitation with the single breath-hold 3D MRE sequence to retrieve the magnitude of the complex-valued shear modulus (|G*| [kPa]), the shear wave speed (Cs [m/s]), and the loss modulus (G" [kPa]). Additionally, the controls were scanned with a multiple–breath-hold 3D MRE sequence for comparison, and the participants had histopathology (Ishak scores) for correlation with Cs and G".

Among the 10 controls, five were female with a mean age and body mass index of 33.1 ± 9.5 years and 23.0 ± 2.1 kg/m2, respectively. Among the 10 participants, eight were female with a mean age and body mass index of 45.1 ± 16.5 years and 33.1 ± 4.0 kg/m2 (obese range), respectively. All the study participants were suspected of having nonalcoholic fatty liver disease. Bland-Altman analysis of the comparison in controls exhibited non-significant differences in |G*|, Cs, and G" below 6.5%, indicating good consensus between the two sequences. For the participants, Cs and G" correlated significantly with Ishak fibrosis and inflammation grades, respectively (ρ = 0.95, P < 0.001, and ρ = 0.84, P = 0.002). Based on the findings, the researchers concluded that the single breath-hold 3D MRE sequence may be effective in measuring liver fibrosis and inflammation in obese patients.

“Non-alcoholic fatty live disease is a health crisis across the globe and evaluating patients in a time efficient fashion is becoming of high importance in medicine,” said Omar Darwish, PhD student, School of Biomedical Engineering & Imaging Sciences. “Liver biopsy is invasive, costly, and accompanied with complications. These could be mitigated by a successful proof of concept in 3D MRE sequencing and warrants a larger clinical study to further evaluate diagnostic accuracy and performance.”

Related Links:
King’s College London

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Ultrasound System
Acclarix AX9
New
Ultrasound Needle Guide
Ultra-Pro II

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.